Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Cardiovascular Market Research

Global Injectable Anticoagulants Market Research Report 2022

Best Price Guarantee Length Publisher Published Date SKU
from $2,900 77 Pages QYResearch Group January, 2022 QYR16931628
Best Price Guarantee
Price from $2,900
Length 77 Pages
Publisher QYResearch Group
Published Date January, 2022
SKU QYR16931628

Global Injectable Anticoagulants Market Research Report 2022

Summary

Market Analysis and Insights: Global Injectable Anticoagulants Market
The global Injectable Anticoagulants market size is projected to reach US$ 9907.8 million by 2028, from US$ 6667.5 million in 2021, at a CAGR of 5.60% during 2022-2028.
Low-Molecular-Weight Heparin (LMWH) accounting for 50.07% of the Injectable Anticoagulants global market in 2021, is projected to value US$ 5353.2 million by 2028, growing at a revised 6.64% CAGR in the forecast period. While VTE segment is altered to a 5.51% CAGR throughout this forecast period.
China Injectable Anticoagulants market size is valued at US$ 1102.7 million in 2021, while the North America and Europe Injectable Anticoagulants are US$ 2111.3 million and US$ 2283.7 million, severally. The proportion of the North America is 31.67% in 2021, while China and Europe are 16.54% and 34.25% respectively, and it is predicted that China proportion will reach 24.13% in 2028, trailing a CAGR of 11.44% through the analysis period. As for the Europe Injectable Anticoagulants landscape, Germany is projected to reach US$ 680.3 million by 2028 trailing a CAGR of 2.55% over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Injectable Anticoagulants market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Injectable Anticoagulants market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Injectable Anticoagulants market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Injectable Anticoagulants market.
Global Injectable Anticoagulants Scope and Market Size
Injectable Anticoagulants market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Anticoagulants market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
By Company
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Aspen
Pfizer
Hepalink
King-friend
CSBIO
Amphastar Pharmaceuticals

Segment by Type
LMWH
Unfractionated Heparin
Fibrinolytics
Other

Segment by Application
VTE
ACS/MI
AF
Other

By Region
North America
United States
Canada

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia

Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe

Latin America
Mexico
Brazil
Rest of Latin America

Middle East & Africa
GCC
Turkey
South Africa
Rest of MEA


1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Anticoagulants Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Low-Molecular-Weight Heparin (LMWH)
1.2.3 Unfractionated Heparin
1.2.4 Fibrinolytics
1.2.5 Other
1.3 Market by Application
1.3.1 Global Injectable Anticoagulants Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 AF
1.3.3 VTE
1.3.4 ACS/MI
1.4 Study Objectives
1.5 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Injectable Anticoagulants Market Perspective (2017-2028)
2.2 Injectable Anticoagulants Growth Trends by Region
2.2.1 Injectable Anticoagulants Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Injectable Anticoagulants Historic Market Size by Region (2017-2022)
2.2.3 Injectable Anticoagulants Forecasted Market Size by Region (2023-2028)
2.3 Injectable Anticoagulants Market Dynamics
2.3.1 Injectable Anticoagulants Industry Trends
2.3.2 Injectable Anticoagulants Market Drivers
2.3.3 Injectable Anticoagulants Market Challenges
2.4 Prevalence and Incident Rate of Thrombosis and Protein C/S Deficiency
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Injectable Anticoagulants Players by Revenue
3.1.1 Global Top Injectable Anticoagulants Players by Revenue (2017-2022)
3.1.2 Global Injectable Anticoagulants Revenue Market Share by Players (2017-2022)
3.2 Players Covered: Ranking by Injectable Anticoagulants Revenue
3.3 Global Injectable Anticoagulants Market Concentration Ratio
3.3.1 Global Injectable Anticoagulants Market Concentration Ratio (CR5)
3.3.2 Global Top 3 and Top 5 Companies by Injectable Anticoagulants Revenue in 2021
3.4 Injectable Anticoagulants Key Players Head office and Area Served
3.5 Key Players Injectable Anticoagulants Product Solution and Service
3.6 Establish Date of Injectable Anticoagulants Players
3.7 Mergers & Acquisitions, Expansion Plans
4 INJECTABLE ANTICOAGULANTS BREAKDOWN DATA BY TYPE
4.1 Global Injectable Anticoagulants Historic Market Size by Type (2017-2022)
4.2 Global Injectable Anticoagulants Forecasted Market Size by Type (2023-2028)
5 INJECTABLE ANTICOAGULANTS BREAKDOWN DATA BY APPLICATION
5.1 Global Injectable Anticoagulants Historic Market Size by Application (2017-2022)
5.2 Global Injectable Anticoagulants Forecasted Market Size by Application (2023-2028)
6 NORTH AMERICA
6.1 North America Injectable Anticoagulants Market Size (2017-2028)
6.2 North America Injectable Anticoagulants Market Size by Country (2017-2022)
6.3 North America Injectable Anticoagulants Market Share by Country (2023-2028)
6.4 United States
6.5 Canada
7 EUROPE
7.1 Europe Injectable Anticoagulants Market Size (2017-2028)
7.2 Europe Injectable Anticoagulants Market Size by Country (2017-2022)
7.3 Europe Injectable Anticoagulants Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
8 ASIA-PACIFIC
8.1 Asia-Pacific Injectable Anticoagulants Market Size (2017-2028)
8.2 Asia-Pacific Injectable Anticoagulants Market Size by Region (2017-2022)
8.3 Asia-Pacific Injectable Anticoagulants Market Size by Region (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 LATIN AMERICA
9.1 Latin America Injectable Anticoagulants Market Size (2017-2028)
9.2 Latin America Injectable Anticoagulants Market Size by Country (2017-2022)
9.3 Latin America Injectable Anticoagulants Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Injectable Anticoagulants Market Size (2017-2028)
10.2 Middle East & Africa Injectable Anticoagulants Market Size by Country (2017-2022)
10.3 Middle East & Africa Injectable Anticoagulants Market Size by Country (2023-2028)
10.4 Turkey
10.5 GCC
10.6 South Africa
11 KEY PLAYERS PROFILES
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Injectable Anticoagulants Introduction
11.1.4 Sanofi Revenue in Injectable Anticoagulants Business (2017-2022)
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Company Details
11.2.2 Genentech (Roche) Business Overview
11.2.3 Genentech (Roche) Injectable Anticoagulants Introduction
11.2.4 Genentech (Roche) Revenue in Injectable Anticoagulants Business (2017-2022)
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Injectable Anticoagulants Introduction
11.3.4 Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2017-2022)
11.4 Aspen
11.4.1 Aspen Company Details
11.4.2 Aspen Business Overview
11.4.3 Aspen Injectable Anticoagulants Introduction
11.4.4 Aspen Revenue in Injectable Anticoagulants Business (2017-2022)
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Injectable Anticoagulants Introduction
11.5.4 Pfizer Revenue in Injectable Anticoagulants Business (2017-2022)
11.6 Hepalink
11.6.1 Hepalink Company Details
11.6.2 Hepalink Business Overview
11.6.3 Hepalink Injectable Anticoagulants Introduction
11.6.4 Hepalink Revenue in Injectable Anticoagulants Business (2017-2022)
11.7 King-friend
11.7.1 King-friend Company Details
11.7.2 King-friend Business Overview
11.7.3 King-friend Injectable Anticoagulants Introduction
11.7.4 King-friend Revenue in Injectable Anticoagulants Business (2017-2022)
11.8 CSBIO
11.8.1 CSBIO Company Details
11.8.2 CSBIO Business Overview
11.8.3 CSBIO Injectable Anticoagulants Introduction
11.8.4 CSBIO Revenue in Injectable Anticoagulants Business (2017-2022)
11.9 Amphastar Pharmaceuticals
11.9.1 Amphastar Pharmaceuticals Company Details
11.9.2 Amphastar Pharmaceuticals Business Overview
11.9.3 Amphastar Pharmaceuticals Injectable Anticoagulants Introduction
11.9.4 Amphastar Pharmaceuticals Revenue in Injectable Anticoagulants Business (2017-2022)
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Injectable Anticoagulants Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Global Injectable Anticoagulants Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 3. Global Injectable Anticoagulants Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 4. Global Injectable Anticoagulants Market Size by Region (2017-2022) & (US$ Million)
Table 5. Global Injectable Anticoagulants Market Share by Region (2017-2022)
Table 6. Global Injectable Anticoagulants Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 7. Global Injectable Anticoagulants Market Share by Region (2023-2028)
Table 8. Injectable Anticoagulants Market Trends
Table 9. Injectable Anticoagulants Market Drivers
Table 10. Injectable Anticoagulants Market Challenges
Table 11. Global Injectable Anticoagulants Revenue by Players (2017-2022) & (US$ Million)
Table 12. Global Injectable Anticoagulants Market Share by Players (2017-2022)
Table 13. Ranking of Global Top Injectable Anticoagulants Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Injectable Anticoagulants Revenue (CR5) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Injectable Anticoagulants Product Solution and Service
Table 17. Establish Date of Injectable Anticoagulants Players
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Injectable Anticoagulants Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Injectable Anticoagulants Revenue Market Share by Type (2017-2022)
Table 21. Global Injectable Anticoagulants Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Injectable Anticoagulants Revenue Market Share by Type (2023-2028)
Table 23. Global Injectable Anticoagulants Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Injectable Anticoagulants Revenue Market Share by Application (2017-2022)
Table 25. Global Injectable Anticoagulants Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Injectable Anticoagulants Revenue Market Share by Application (2023-2028)
Table 27. North America Injectable Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 28. North America Injectable Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 29. Europe Injectable Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 30. Europe Injectable Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 31. Asia-Pacific Injectable Anticoagulants Market Size by Region (2017-2022) & (US$ Million)
Table 32. Asia-Pacific Injectable Anticoagulants Market Size by Region (2023-2028) & (US$ Million)
Table 33. Latin America Injectable Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 34. Latin America Injectable Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 35. Middle East & Africa Injectable Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 36. Middle East & Africa Injectable Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 37. Sanofi Company Details
Table 38. Sanofi Business Overview
Table 39. Sanofi Injectable Anticoagulants Product
Table 40. Sanofi Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 41. Genentech (Roche) Company Details
Table 42. Genentech (Roche) Business Overview
Table 43. Genentech (Roche) Injectable Anticoagulants Product
Table 44. Genentech (Roche) Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 45. Boehringer Ingelheim Company Details
Table 46. Boehringer Ingelheim Business Overview
Table 47. Boehringer Ingelheim Injectable Anticoagulants Product
Table 48. Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 49. Aspen Company Details
Table 50. Aspen Business Overview
Table 51. Aspen Injectable Anticoagulants Product
Table 52. Aspen Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 53. Pfizer Company Details
Table 54. Pfizer Business Overview
Table 55. Pfizer Injectable Anticoagulants Product
Table 56. Pfizer Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 57. Hepalink Company Details
Table 58. Hepalink Business Overview
Table 59. Hepalink Injectable Anticoagulants Product
Table 60. Hepalink Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 61. King-friend Company Details
Table 62. King-friend Business Overview
Table 63. King-friend Injectable Anticoagulants Product
Table 64. King-friend Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 65. CSBIO Company Details
Table 66. CSBIO Business Overview
Table 67. CSBIO Injectable Anticoagulants Product
Table 68. CSBIO Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 69. Amphastar Pharmaceuticals Company Details
Table 70. Amphastar Pharmaceuticals Business Overview
Table 71. Amphastar Pharmaceuticals Injectable Anticoagulants Product
Table 72. Amphastar Pharmaceuticals Revenue in Injectable Anticoagulants Business (2017-2022) & (US$ Million)
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Anticoagulants Market Share by Type: 2021
Figure 2. Global Injectable Anticoagulants Market Share by Application: 2021
Figure 3. Injectable Anticoagulants Report Years Considered
Figure 4. Global Injectable Anticoagulants Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 5. Global Injectable Anticoagulants Market Share by Region: 2021

$2,900
$5,800

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings